Infectious Diseases News

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The American Academy of Dermatology has created a measles resource center for dermatologists to stay prepared during the current U.S. measles outbreak.

SAN FRANCISCO — A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk for long COVID, according to study data.

SAN FRANCISCO — Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic Infections.

SAN FRANCISCO — A universal syphilis screening program identified more cases of syphilis than programs targeting specific patient populations, such as pregnant women and patients already receiving blood draws, researchers found.

Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective antibodies that persisted for up to a year after vaccination with no significant safety events, researchers found.

SAN FRANCISCO — Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, baseline suppressive therapies among adults with HIV.

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

SAN FRANCISCO — Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic Infections.